معرفی
Dr. Nida Sajid Ali is a Lecturer at the School of Pharmacy, Monash University, Malaysia. Her research focuses on clinical oncology, particularly prognostic and predictive factors influencing treatment plans and survival outcomes in cancer patients. She also explores broader pharmacy practice issues like medication adherence and patient communication skills training.
Her academic journey includes a postgraduate research degree completed in 2017 and a transition to Monash University in 2019. Research interests span cancer treatment modalities, molecular biomarkers (e.g., EGFR mutations), and supportive care strategies for cachexia/malnutrition in oncology patients.
Notable contributions include studies on gefitinib efficacy in lung cancer, mHealth adoption patterns, and the impact of smoking on adenocarcinoma outcomes. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being).
Publications highlight interdisciplinary approaches combining clinical oncology with pharmacoepidemiology and digital health innovation. She has no listed awards but demonstrates active research collaboration in Malaysia and international journals.
